Beijing Wantai Biological Pharmacy Enterprise Co Ltd (603392) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.010x

Based on the latest financial reports, Beijing Wantai Biological Pharmacy Enterprise Co Ltd (603392) has a cash flow conversion efficiency ratio of 0.010x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥127.35 Million ≈ $18.63 Million USD) by net assets (CN¥12.27 Billion ≈ $1.80 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Beijing Wantai Biological Pharmacy Enterprise Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Beijing Wantai Biological Pharmacy Enterprise Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Beijing Wantai Biological Pharmacy Enter for a breakdown of total debt and financial obligations.

Beijing Wantai Biological Pharmacy Enterprise Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Beijing Wantai Biological Pharmacy Enterprise Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Companhia Paranaense de Energia - COPEL NYSE:ELPC	0.006x
Kiwoom KO:039490	0.143x
Charles River Laboratories NYSE:CRL	0.062x
Sunny Optical Technology (Group) Company Limited F:SXC	0.020x
Vibra Energia S.A. SA:VBBR3	0.136x
Vicinity Centres AU:VCX	0.028x
The Federal Bank Limited NSE:FEDERALBNK	0.083x
Storebrand ASA OL:STB	0.363x

Annual Cash Flow Conversion Efficiency for Beijing Wantai Biological Pharmacy Enterprise Co Ltd (2013–2024)

The table below shows the annual cash flow conversion efficiency of Beijing Wantai Biological Pharmacy Enterprise Co Ltd from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see 603392 stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥12.45 Billion ≈ $1.82 Billion	CN¥355.08 Million ≈ $51.96 Million	0.029x	-77.09%
2023-12-31	CN¥12.88 Billion ≈ $1.89 Billion	CN¥1.60 Billion ≈ $234.72 Million	0.125x	-62.15%
2022-12-31	CN¥12.56 Billion ≈ $1.84 Billion	CN¥4.13 Billion ≈ $604.73 Million	0.329x	-10.78%
2021-12-31	CN¥4.56 Billion ≈ $667.64 Million	CN¥1.68 Billion ≈ $246.12 Million	0.369x	+103.17%
2020-12-31	CN¥2.58 Billion ≈ $377.59 Million	CN¥468.21 Million ≈ $68.51 Million	0.181x	+5.19%
2019-12-31	CN¥1.58 Billion ≈ $231.31 Million	CN¥272.68 Million ≈ $39.90 Million	0.173x	+13.49%
2018-12-31	CN¥1.37 Billion ≈ $200.54 Million	CN¥208.31 Million ≈ $30.48 Million	0.152x	-7.02%
2017-12-31	CN¥898.99 Million ≈ $131.55 Million	CN¥146.97 Million ≈ $21.51 Million	0.163x	+21.25%
2016-12-31	CN¥959.70 Million ≈ $140.43 Million	CN¥129.40 Million ≈ $18.94 Million	0.135x	-35.82%
2015-12-31	CN¥722.69 Million ≈ $105.75 Million	CN¥151.84 Million ≈ $22.22 Million	0.210x	-7.93%
2014-12-31	CN¥580.32 Million ≈ $84.92 Million	CN¥132.43 Million ≈ $19.38 Million	0.228x	-10.88%
2013-12-31	CN¥382.06 Million ≈ $55.91 Million	CN¥97.83 Million ≈ $14.32 Million	0.256x	--

About Beijing Wantai Biological Pharmacy Enterprise Co Ltd

SHG:603392 China Biotechnology

Market Cap

$7.92 Billion

CN¥54.10 Billion CNY

Market Cap Rank

#2647 Global

#337 in China

Share Price

CN¥42.79

Change (1 day)

+5.21%

52-Week Range

CN¥37.95 - CN¥78.36

All Time High

CN¥142.90